Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | G protein-coupled receptor 35 | Starlite/ChEMBL | No references |
Homo sapiens | protein tyrosine phosphatase, non-receptor type 7 | Starlite/ChEMBL | No references |
Homo sapiens | protein tyrosine phosphatase, non-receptor type 12 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | receptor type tyrosine protein phosphatase | protein tyrosine phosphatase, non-receptor type 7 | 434 aa | 400 aa | 24.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | transglycolase/transpeptidase | 0.0331 | 0.0196 | 0.3865 |
Trichomonas vaginalis | glutaminase, putative | 0.0268 | 0.0154 | 0.5329 |
Mycobacterium ulcerans | glutaminase | 0.0268 | 0.0154 | 0.0192 |
Mycobacterium leprae | POSSIBLE PENICILLIN-BINDING LIPOPROTEIN | 0.043 | 0.0261 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.0054 | 0.352 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.023 | 0.0129 | 1 |
Mycobacterium tuberculosis | Probable penicillin-binding membrane protein PbpB | 0.0168 | 0.0088 | 0.0014 |
Mycobacterium leprae | PROBABLE BIFUNCTIONAL MEMBRANE-ASSOCIATED PENICILLIN-BINDING PROTEIN 1A/1B PONA2 (MUREIN POLYMERASE) [INCLUDES: PENICILLIN-INSEN | 0.047 | 0.0288 | 0.04 |
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.0008 | 0.0008 |
Echinococcus multilocularis | cysteinyl tRNA synthetase | 0.0117 | 0.0054 | 0.4198 |
Wolbachia endosymbiont of Brugia malayi | cell division protein FtsI | 0.0671 | 0.042 | 1 |
Trypanosoma cruzi | cysteinyl-tRNA synthetase, putative | 0.0117 | 0.0054 | 1 |
Mycobacterium leprae | Probable penicillin-binding membrane protein PbpB | 0.0168 | 0.0088 | 0.0014 |
Mycobacterium tuberculosis | Possible penicillin-binding lipoprotein | 0.043 | 0.0261 | 0.0349 |
Brugia malayi | cysteinyl tRNA synthetase protein 1 | 0.0117 | 0.0054 | 0.352 |
Leishmania major | cysteinyl-tRNA synthetase, putative | 0.0117 | 0.0054 | 1 |
Trypanosoma brucei | cysteinyl-tRNA synthetase, putative | 0.0117 | 0.0054 | 1 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0047 | 0.0008 | 0.0543 |
Toxoplasma gondii | cysteine-tRNA synthetase (CysRS) | 0.0117 | 0.0054 | 1 |
Mycobacterium tuberculosis | Cysteine:1D-myo-inosityl 2-amino-2-deoxy--D-glucopyranoside ligase MshC | 0.7998 | 0.5256 | 1 |
Entamoeba histolytica | cysteinyl-tRNA synthetase, putative | 0.0117 | 0.0054 | 1 |
Mycobacterium tuberculosis | Probable penicillin-binding protein PbpA | 0.0333 | 0.0197 | 0.0225 |
Brugia malayi | hypothetical protein | 0.023 | 0.0129 | 0.8384 |
Plasmodium falciparum | cysteine--tRNA ligase | 0.0117 | 0.0054 | 1 |
Brugia malayi | glutaminase DH11.1 | 0.0268 | 0.0154 | 1 |
Mycobacterium ulcerans | penicillin-binding membrane protein PbpB | 0.067 | 0.0419 | 0.0702 |
Schistosoma mansoni | glutaminase | 0.0268 | 0.0154 | 0.0154 |
Mycobacterium leprae | PROBABLE BIFUNCTIONAL PENICILLIN-BINDING PROTEIN 1A/1B PONA1 (MUREIN POLYMERASE) (PBP1): PENICILLIN-INSENSITIVE TRANSGLYCOSYLASE | 0.0473 | 0.029 | 0.0404 |
Echinococcus granulosus | leucyl tRNA synthetase | 0.0117 | 0.0054 | 0.4198 |
Treponema pallidum | penicillin-binding protein (pbp-2) | 0.0473 | 0.029 | 0.5028 |
Plasmodium vivax | cysteine--tRNA ligase, putative | 0.0117 | 0.0054 | 1 |
Mycobacterium ulcerans | penicillin-binding protein PbpA | 0.0333 | 0.0197 | 0.0274 |
Loa Loa (eye worm) | hypothetical protein | 0.023 | 0.0129 | 0.8384 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0473 | 0.029 | 1 |
Plasmodium falciparum | cysteine--tRNA ligase | 0.0117 | 0.0054 | 1 |
Mycobacterium ulcerans | bifunctional penicillin-binding protein 1A/1B PonA1 | 0.0473 | 0.029 | 0.0452 |
Schistosoma mansoni | cysteinyl-tRNA synthetase | 0.0117 | 0.0054 | 0.0054 |
Treponema pallidum | penicillin-binding protein (pbp-3) | 0.0826 | 0.0522 | 1 |
Mycobacterium tuberculosis | Probable bifunctional membrane-associated penicillin-binding protein 1A/1B PonA2 (murein polymerase) [includes: penicillin-insen | 0.047 | 0.0288 | 0.04 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.023 | 0.0129 | 1 |
Treponema pallidum | penicillin-binding protein (pbp-1) | 0.0671 | 0.042 | 0.7821 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0073 | 0.4697 |
Mycobacterium tuberculosis | Probable bifunctional penicillin-binding protein 1A/1B PonA1 (murein polymerase) (PBP1): penicillin-insensitive transglycosylase | 0.0159 | 0.0083 | 0.0004 |
Onchocerca volvulus | 0.0117 | 0.0054 | 1 | |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0073 | 0.4697 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0073 | 0.4697 |
Mycobacterium leprae | Probable penicillin-binding protein PbpA | 0.0333 | 0.0197 | 0.0225 |
Mycobacterium leprae | Probable cysteine:1D-myo-inosityl 2-amino-2-deoxy--D-glucopyranoside ligase MshC | 0.7998 | 0.5256 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0268 | 0.0154 | 1 |
Schistosoma mansoni | cysteinyl-tRNA synthetase | 0.0117 | 0.0054 | 0.0054 |
Chlamydia trachomatis | transglycolase/transpeptidase | 0.0671 | 0.042 | 1 |
Schistosoma mansoni | family A2 unassigned peptidase (A02 family) | 0.2761 | 0.18 | 0.18 |
Trypanosoma cruzi | cysteinyl-tRNA synthetase, putative | 0.0117 | 0.0054 | 1 |
Mycobacterium ulcerans | bifunctional membrane-associated penicillin-binding protein 1A/1B PonA2 | 0.047 | 0.0288 | 0.0449 |
Mycobacterium ulcerans | serine/threonine-protein kinase B PknB | 0.0156 | 0.008 | 0.005 |
Mycobacterium ulcerans | penicillin-binding lipoprotein | 0.043 | 0.0261 | 0.0398 |
Schistosoma mansoni | survival motor neuron protein | 0.0047 | 0.0008 | 0.0008 |
Loa Loa (eye worm) | glutaminase | 0.0268 | 0.0154 | 1 |
Trichomonas vaginalis | cysteinyl-tRNA synthetase, putative | 0.0117 | 0.0054 | 0.1876 |
Loa Loa (eye worm) | cysteinyl tRNA synthetase 1 | 0.0117 | 0.0054 | 0.352 |
Treponema pallidum | hypothetical protein | 0.0156 | 0.008 | 0.0559 |
Echinococcus granulosus | cysteinyl tRNA synthetase | 0.0117 | 0.0054 | 0.4198 |
Mycobacterium ulcerans | cysteinyl-tRNA synthetase | 0.7998 | 0.5256 | 1 |
Giardia lamblia | Cysteinyl-tRNA synthetase | 0.0117 | 0.0054 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.5218 um | PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ] | ChEMBL. | No reference |
IC50 (functional) | = 9.74 uM | PUBCHEM_BIOASSAY: SAR analysis of compounds that inhibit HePTP - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1059, AID1077, AID1784, AID2085, AID521] | ChEMBL. | No reference |
IC50 (functional) | = 17.9 uM | PUBCHEM_BIOASSAY: SAR Selectivity Analysis of small molecule inhibitors of PEST using pCAP in a fluorescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1779, AID1784, AID2135] | ChEMBL. | No reference |
IC50 (functional) | > 32 uM | PUBCHEM_BIOASSAY: SAR Analysis of Selective Antagonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079] | ChEMBL. | No reference |
IC50 (functional) | = 58.5 uM | PUBCHEM_BIOASSAY: SAR LYP1 Fluorescent Assay using pCAP substrate for In Vitro dose response studies - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1779, AID1784, AID2135, AID2682] | ChEMBL. | No reference |
IC50 (functional) | > 100 uM | PUBCHEM_BIOASSAY: SAR LYP1 Fluorescent Assay using OMFP substrate for In Vitro dose response studies - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1779, AID1784, AID2140, AID2686] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.